Genmab — August 2015
-
Det er derfor Genmab ikke skal opkøbes af big Pharma. Der er kæmpe værdi i der teknologier
-
Vi mangler bare den IND fra J&J snart så vi kan se hvad DuoBody kan i mennesker også
-
Der har vi lige været.
-
Hvis bare vi kan blive her omkring 630-650 indtil dara approval er jeg fint tilfreds
-
Ordentlig prop i 640
-
Det er sgu sjældent at vi ser en sådan "spærre" i GEN.
-
10.000 tager du lige dem?
-
Tror det er "encifret" royalty %
-
jeg vil sige maks 9,99 %
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind